News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,994 Results
Type
Article (88219)
Company Profile (823)
Press Release (784931)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233359)
Career Advice (4152)
Deals (39899)
Drug Delivery (159)
Drug Development (91490)
Employer Resources (205)
FDA (18448)
Job Trends (17442)
News (398164)
Policy (39998)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3025)
Academic (2)
Accelerated approval (41)
Adcomms (37)
Allergies (166)
Alliances (56982)
ALS (194)
Alzheimer's disease (1830)
Antibody-drug conjugate (ADC) (383)
Approvals (18649)
Artificial intelligence (692)
Autoimmune disease (210)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (213)
Biotechnology (490)
Bladder cancer (177)
Brain cancer (70)
Breast cancer (704)
Cancer (5398)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (880)
Cervical cancer (41)
Clinical research (77518)
Collaboration (1982)
Company closure (6)
Compensation (1261)
Complete response letters (84)
COVID-19 (3006)
CRISPR (110)
C-suite (985)
Cystic fibrosis (157)
Data (6790)
Decentralized trials (2)
Denatured (77)
Depression (168)
Diabetes (556)
Diagnostics (7340)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (336)
Drug pricing (231)
Drug shortages (36)
Duchenne muscular dystrophy (267)
Earnings (100858)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135995)
Executive appointments (1080)
FDA (21853)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1661)
Gene editing (234)
Generative AI (72)
Gene therapy (726)
GLP-1 (1176)
Government (5487)
Grass and pollen (8)
Guidances (390)
Healthcare (20987)
HIV (76)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (312)
Immuno-oncology (78)
Indications (138)
Infectious disease (3329)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (269)
Interviews (817)
IPO (17972)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (720)
Lymphoma (399)
Machine learning (49)
Management (66)
Manufacturing (940)
MASH (186)
Medical device (15101)
Medtech (15169)
Mergers & acquisitions (23056)
Metabolic disorders (1499)
mRNA (203)
Multiple sclerosis (181)
NASH (23)
Neurodegenerative disease (392)
Neuropsychiatric disorders (110)
Neuroscience (3275)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (736)
Opinion (350)
Ovarian cancer (177)
Pain (236)
Pancreatic cancer (256)
Parkinson's disease (323)
Partnered (39)
Patents (552)
Patient recruitment (566)
Peanut (65)
People (67210)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23947)
Phase 2 (33638)
Phase 3 (25345)
Pipeline (6324)
Policy (362)
Postmarket research (3554)
Preclinical (10735)
Press Release (72)
Prostate cancer (275)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1036)
Real estate (7445)
Recruiting (81)
Regulatory (29414)
Reports (69)
Research institute (2747)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (91)
Schizophrenia (166)
Series A (280)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (122)
Tariffs (101)
The Weekly (129)
Vaccines (1197)
Venture capital (103)
Weight loss (502)
Women's health (108)
Worklife (23)
Date
Today (164)
Last 7 days (735)
Last 30 days (3221)
Last 365 days (32838)
2026 (6310)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (357)
Arkansas (15)
Asia (51723)
Australia (9089)
California (12328)
Canada (3506)
China (1248)
Colorado (521)
Connecticut (539)
Delaware (366)
Europe (119055)
Florida (1833)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1031)
India (82)
Indiana (579)
Iowa (24)
Japan (473)
Kansas (135)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1529)
Massachusetts (9059)
Michigan (381)
Minnesota (697)
Mississippi (7)
Missouri (148)
Montana (37)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3315)
New Mexico (33)
New York (3248)
North Carolina (1696)
North Dakota (10)
Northern California (5973)
Ohio (379)
Oklahoma (23)
Oregon (55)
Pennsylvania (2454)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (71)
South Dakota (1)
Southern California (4779)
Tennessee (196)
Texas (1944)
United States (44361)
Utah (371)
Vermont (1)
Virginia (311)
Washington D.C. (88)
Washington State (1020)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,994 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IgA nephropathy
Vertex’s Nephropathy Asset Delivers ‘Strong’ Late-Stage Data, Clears Path to FDA
Vertex Pharmaceuticals has a rolling biologics license application with the FDA for povetaciceptin IgA nephropathy. With new data from RAINIER, the biotech expects to complete its submission by the end of March.
March 10, 2026
·
2 min read
·
Tristan Manalac
Press Releases
For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025
March 10, 2026
·
3 min read
Press Releases
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology
March 10, 2026
·
9 min read
Press Releases
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
March 10, 2026
·
8 min read
Press Releases
EnteroBiotix Announces Completion of Enrolment in Phase 2a Trial Evaluating EBX-102-02 Prior to Allogeneic Stem Cell Transplantation
March 10, 2026
·
4 min read
Press Releases
TECVAYLI®▼ (teclistamab) monotherapy application submitted to the EMA for relapsed/refractory multiple myeloma after at least one prior therapy
March 10, 2026
·
12 min read
Press Releases
Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors
March 10, 2026
·
5 min read
Press Releases
The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
March 10, 2026
·
2 min read
Press Releases
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
·
2 min read
Press Releases
Press Release Biocartis NV: Biocartis Receives European IVDR Certification for the Idylla™ CDx MSI Test
March 10, 2026
·
2 min read
1 of 87,400
Next
